CoChat

Inhibiting glycogen synthase kinase‐3 reduces endotoxaemic acute renal failure by down‐regulating inflammation and renal cell apoptosis

Open access
Wang, Y, Huang, WC, Wang, CY, Tsai, CC, Chen, CL, Chang, YT, Kai, JI, Lin, CF · 2009 · British Journal of Pharmacology
Cited by 74

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

Background and purpose: Excessive inflammation and apoptosis are pathological features of endotoxaemic acute renal failure. Activation of glycogen synthase kinase‐3 (GSK‐3) is involved in inflammation and apoptosis. We investigated the effects of inhibiting GSK‐3 on lipopolysaccharide (LPS)‐induced acute renal failure, nuclear factor‐κB (NF‐κB), inflammation and apoptosis. Experimental approach: The effects of inhibiting GSK‐3 with inhibitors, including lithium chloride (LiCl) and 6‐bromo‐indirubin‐3′‐oxime (BIO), on LPS‐treated (15 mg·kg−1) C3H/HeN mice (LiCl, 40 mg·kg−1 and BIO, 2 mg·kg−1) and LPS‐treated (1 µg·mL−1) renal epithelial cells (LiCl, 20 mM and BIO, 5 µM) were studied. Mouse survival was monitored and renal function was analysed by histological and serological examination. Cytokine and chemokine production, and cell apoptosis were measured by enzyme‐linked immunosorbent assay and terminal deoxynucleotidyl transferase‐mediated dUTP–biotin nick‐end labelling staining, respectively. Activation of NF‐κB and GSK‐3 was determined by immunostaining and Western blotting, respectively. Key results: Mice treated with GSK‐3 inhibitors showed decreased mortality, renal tubular dilatation, vacuolization and sloughing, blood urea nitrogen, creatinine and renal cell apoptosis in response to endotoxaemia. Inhibiting GSK‐3 reduced LPS‐induced tumour necrosis factor‐α (TNF‐α) and CCL5/RANTES (released upon activation of normal T‐cells) in vivo in mice and in vitro in murine kidney cortical collecting duct epithelial M1 cells. Inhibiting GSK‐3 did not block TNF‐α‐induced cytotoxicity in rat kidney proximal tubular epithelial NRK52E or in M1 cells. Conclusions and implications: These results suggest that GSK‐3 inhibition protects against endotoxaemic acute renal failure mainly by down‐regulating pro‐inflammatory TNF‐α and RANTES.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1476-5381.2009.00284.x

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 74

Metadata

Authors
Wang, Y., Huang, W., Wang, C., Tsai, C., Chen, C., Chang, Y., Kai, J., & Lin, C.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2009-07
Volume
157
Issue
6
Pages
1004-1013
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2075584371
Cited by
74
References
3
FWCI
3.30
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Inhibiting glycogen synthase kinase‐3 reduces endotoxaemic acute renal failure by down‐regulating inflammation and renal cell apoptosis. https://app.cochat.ai/papers/10.1111/j.1476-5381.2009.00284.x
The paper
Wang, Y., Huang, W., Wang, C., Tsai, C., Chen, C., Chang, Y., Kai, J., & Lin, C. (2009). Inhibiting glycogen synthase kinase‐3 reduces endotoxaemic acute renal failure by down‐regulating inflammation and renal cell apoptosis. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.2009.00284.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.